Nuix Limited (ASX:NXL)
Australia · Delayed Price · Currency is AUD | Market Cap | 450.54M -42.5% |
| Revenue (ttm) | 237.49M +4.5% |
| Net Income | 12.27M |
| EPS | 0.03 |
| Shares Out | 338.75M |
| PE Ratio | 43.30 |
| Forward PE | 17.55 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 992,414 |
| Average Volume | 1,352,456 |
| Open | 1.430 |
| Previous Close | 1.430 |
| Day's Range | 1.330 - 1.435 |
| 52-Week Range | 1.070 - 3.350 |
| Beta | 1.97 |
| RSI | 43.20 |
| Earnings Date | Feb 22, 2026 |
About Nuix Limited
Nuix Limited provides investigative analytics and intelligence software solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company offers Nuix Workstation, a solution for processing file formats and source types into meaningful information by capturing the content, metadata, and context; Nuix Discover that provides processing, analytics, and machine learning-powered review in a single platform; and Nuix Investigate, a solution which extracts, correlates, and contextualizes various types of data types, across p... [Read more]
Financial Performance
Financial StatementsNews
Nuix Limited Earnings Call Transcript: H1 2026
ACV grew 8.4% year-over-year to AUD 234.4 million, with Nuix Neo ACV up 148% and revenue up 15.2%. Adjusted management EBITDA rose 42.6%, and cash flow improved significantly. The Neo migration program and AI positioning are driving transformation and future growth.
Nuix Wins Multiyear Contract with German Tax Authority to Strengthen Investigative and Regulatory Capabilities
SYDNEY , Sept. 17, 2025 /PRNewswire/ -- Nuix ('the Company', ASX: NXL) today announces it has won a multiyear contract to supply forensic analysis software to the tax authority of German state Rhinela...
Nuix Limited Earnings Call Transcript: H2 2025
ACV grew 8% to AUD 228.4 million, led by 132% growth in Nuix Neo, while cash EBITDA rose 24.5% to AUD 37.2 million. Revenue was flat due to fewer multi-year deals, and churn increased among lower-value customers as focus shifted to larger contracts.
Nuix Limited Earnings Call Transcript: H1 2025
ACV grew 8.3% year-over-year to AUD 216.2 million, with strong subscription momentum and a 30.6% rise in cash EBITDA. Nuix Neo platform adoption is driving larger deals, and full-year ACV growth is expected in the 11%-16% range, with positive cash flow and revenue growth outpacing costs.
Nuix Limited Transcript: AGM 2024
The meeting highlighted strong FY24 financial growth, successful launch of the Nuix Neo platform, and strategic progress in innovation and market expansion. Board and executive changes were noted, and all resolutions were put to a poll with broad shareholder engagement.
Nuix Limited Earnings Call Transcript: H2 2024
FY24 saw robust growth with ACV up 14% and revenue up 20.9%, driven by the successful launch and adoption of the Nuix Neo platform. Profitability and cash flow improved significantly, and the outlook targets 15% ACV growth and continued investment in innovation.
Nuix Limited Earnings Call Transcript: H1 2024
Nuix Limited Transcript: AGM 2023
Nuix Limited Earnings Call Transcript: H2 2023
Nuix Limited Earnings Call Transcript: H1 2023
Why did Nuix (ASX:NXL) shares retreat after spiking 26%?
Nuix (NXL) shares surged more than 25% in the morning of September 9. However, the stock retreated in the afternoon, with its gains coming down to about 15%. The sharp…